Navigation Links
Geneticist develops tool to identify genes important in disease, tailoring individual treatment
Date:5/1/2012

AMHERST, Mass. Though the human genome has been sequenced, scientists are still trying to figure out how the accomplishment can help people, for example, how it can be used to treat disease. As University of Massachusetts Amherst geneticist Jacob Mayfield notes, "It was easy to think of the human genome as the big prize, but what we realize now is, it's just a foot in the door."

"What we're beginning to understand is that the information we're interested in knowing lies in comparisons between genomes," he adds. As society moves to personalized, genome-based medicine, "much work remains for us to grasp what it is that we know. As we uncover new variations at the DNA level, we have to address their consequences. To learn what genetic differences mean to the whole organism, we have to find ways of asking about function. Because the way genes interact to cause traits like red hair isn't understood, let alone how they cause disease!"

To tackle this and make a difference in a human disease, he and colleagues at the University of California Berkeley devised a technique for testing the consequence of variant human gene alleles (alternative sequences of a single gene) by moving them into yeast cells. Once swapped into yeast, colony growth can be compared to reveal functional differences. The technique is reported in the current issue of Genetics.

For this study Mayfield's team first used DNA sequence databases to select variant gene sequences that tested positive for the metabolic disease homocystinuria, which can cause a range of mild to severe symptoms such as blood clots, mental retardation and other problems. Deficiencies in a gene called Cystathionine-beta-synthase (CBS) are often the cause. Because early intervention for homocystinuria can eliminate severe symptoms, newborn screening began in the 1970s.

The researchers selected CBS gene sequences from 84 patients and made a piece of recombinant DNA that matched the
'/>"/>

Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. UC Riverside rice geneticist receives high honor from US Department of Agriculture
2. Powerful online tool for protein analysis provided pro bono by Stanford geneticist
3. Ancient African exodus mostly involved men, geneticists find
4. Is love at first sight real? Geneticists offer tantalizing clues
5. UC Riverside geneticist receives highest honor from Botanical Society of America
6. Geneticists coordinate action to fight against traffic in human beings
7. UBC geneticist reveals molecular view of key epigenetic regulator
8. UK geneticists shed light on flowering plants
9. Case Western Reserve geneticist receives prestigious NIH Directors Pioneer Award
10. Improving cotton the goal of $3.8 million grant to University of Texas at Austin plant geneticist
11. Four new psoriasis hotspots identified by U-M geneticists
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Geneticist develops tool to identify genes important in disease, tailoring individual treatment
(Date:7/9/2015)... July 9, 2015  Synaptics Inc. (NASDAQ: SYNA ), ... that it will report financial results for the fourth ... 2015 after the close of market. The company will ... at 2:00 p.m. PT (5:00 p.m. ET), during which ... participate on the live call, analysts and investors should ...
(Date:7/8/2015)... NEW YORK , July 8, 2015 /PRNewswire/ ... today announced BD & Guidepoint Mentor, a ... access to Guidepoint,s expert network services. ... cutting-edge technologies to improve healthcare delivery and outcomes and, ... each start-up entrepreneur will be able to directly engage ...
(Date:7/7/2015)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a ... a revised version of one of its first 30 second commercials ... in New York , Chicago ... Francisco metro areas.    , , , ... all the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... at the heart of a novel agricultural technique to manage ... can be used to turn carbon dioxide emissions into soil-enriching ... thrives in tropical areas, such as West Africa. ... in dry, acidic soil and treated with a combination of ...
... Researchers at the Instituto Andaluz de Ciencias de la Tierra ... was recently published in the prestigious journal Reviews of ... from 11 different countries has published the most comprehensive study ... the most important contemporary issues in a field of research ...
... Endocrine Society,s Journal of Clinical Endocrinology and Metabolism ... reduce the rate of mortality in seniors, therefore providing ... During the last decade, there has been increasing ... It is well known that calcium with vitamin D ...
Cached Biology News:Bugs have key role in farming approach to storing CO2 emissions 2Spanish scientist participate in the most comprehensive study ever done on ice 2
(Date:8/3/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced today ... Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)...  Merck KGaA, Darmstadt, Germany , ... in the healthcare, life science and performance materials sectors, ... development and launch of promising new fullerene derivatives for ... Darmstadt, Germany , is pursuing many ... Novel derivatives: highly stable, easy to process and ...
(Date:8/3/2015)... , Aug. 3, 2015  Aethlon Medical, Inc. (Nasdaq: ... to treat life-threatening diseases, today announced that it will ... and webcast on Thursday, August 13, 2015 at 4:30 ... will follow the release of fiscal 2016 first quarter ... available approximately two hours after the call at the ...
(Date:8/3/2015)... Md. , Aug. 3, 2015   Intrexon ... will release first half and second quarter 2015 financial ... th , 2015.  The Company will host a conference ... and provide a general business update. The ... US) and 1-412-902-4262 (International), and asking to join the ...
Breaking Biology Technology:MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 2Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 3Merck KGaA, Darmstadt, Germany, and Nano-C Present Enhanced Materials for Organic Photovoltaics 4Aethlon Medical To Host First Quarter Fiscal 2016 Investor Call on August 13, 2015 2Intrexon to Announce First Half and Second Quarter 2015 Financial Results and Host Conference Call on August 10th 2
... today announced that Garry W. Rogerson, President and CEO,will speak ... Thursday,December 4, 2008 at 9:45 a.m. Eastern time. , ... presentation will be publicly available from Varian,Inc.,s Web site at ... on "Investors." An archived replay will be available to ...
... Duska Therapeutics,Inc. (OTC Bulletin Board: DSKA) will host ... its drug development programs and financial results,for the third ... Kuo,MD, MBA, will host the call and there will ... To participate in the teleconference, please ...
... Nov. 20 Cyntellect, a privately-held life,sciences company ... manipulation and purification systems, announced today that it ... University of Florida ,Interdisciplinary Center for Biotechnology Research. ... research areas including the purification and analysis of,cancer ...
Cached Biology Technology:Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 2Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 3Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 4Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 5Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 6Duska Therapeutics Provides Program Update and Reports Third Quarter 2008 Financial Results 7University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 2University of Florida and Cyntellect Collaborate to Unlock Mysteries of Cancer Stem Cells 3
Mouse monoclonal [SPM325] to Xanthine Oxidase, prediluted ( Abpromise for all tested applications). Antigen: C terminal 358 amino acid fragment of human xanthine oxidase. Entrez Gene ID: 749...
Rab1A...
Drugs and NO-drug Rat Anti-conjugated Acetyl Salicylic Acid Polyclonal Antibody...
Applications: Beadlyte® assay Stability: 2 years at 4°C (lyophilized) or 6 months at -20°C (rehydrated) ...
Biology Products: